Adding immune-boosting agent to personalized cancer vaccine supercharges the body's immune defense against malignant brain tumors
University of California, Los Angeles (UCLA), Health SciencesInvestigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor that is fast growing and difficult to treat.